Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort

Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort

Introduction Sex differences in cardiometabolic risk factors and their management in type 2 diabetes (T2D) have not been fully identified. Therefore, we aimed to examine differences in cardiometabolic risk factor levels, pharmacological treatment and achievement of risk factor control between women...

Full description

Bibliographic Details
Main Authors: Femke Rutters, Cees J Tack, Harold W de Valk, J Hans deVries, Miranda T Schram, Coen D A Stehouwer, Bruce H R Wolffenbuttel, Evertine J Abbink, Behiye Özcan, Petra J M Elders, Marieke J Oskam, Sarah E Siegelaar, Marielle Schroijen, Ingrid Jazet, L‘t Hart, N C Schaper, O M Dekkers, B Ozcan, B Silvius, M M van der Klauw
Format: Article
Language:English
Published: BMJ Publishing Group 2020-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/8/1/e001365.full

Internet

https://drc.bmj.com/content/8/1/e001365.full

Similar Items